RVL Pharmaceuticals plc Amortization of Intangible Assets
RVL Pharmaceuticals plc reported Amortization of Intangible Assets of $0 for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2021-11-15
- RVL Pharmaceuticals plc amortization of intangible assets for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- RVL Pharmaceuticals plc amortization of intangible assets for the quarter ending 2021-06-30 was -$2.63M, a 159.86% decline year-over-year.
- RVL Pharmaceuticals plc amortization of intangible assets for the quarter ending 2021-03-31 was $2.63M, a 40.14% decline year-over-year.
- RVL Pharmaceuticals plc amortization of intangible assets for the quarter ending 2020-12-31 was $0.00.
- RVL Pharmaceuticals plc amortization of intangible assets for fiscal 2018 was $77.10M.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$2.63M derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2021-06-30 | -$2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $0.00 derived: sum of 3 quarters · filed 2021-09-08 | $4.20M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2021-03-31 | $2.63M 10-Q · filed 2021-05-13 | $2.63M derived: sum of 2 quarters · filed 2021-09-08 | $6.83M derived: sum of 3 quarters · filed 2021-09-08 | $11.23M derived: sum of 4 quarters · filed 2021-09-08 | ||||
| 2020-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | $4.20M derived: sum of 2 quarters · filed 2021-09-08 | $8.60M derived: sum of 3 quarters · filed 2021-09-08 | $0.00 8-K · filed 2021-09-08 | $16.05M 10-K · filed 2021-03-30 | |||
| 2020-09-30 | $4.20M 10-Q · filed 2020-11-10 | $8.60M derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2021-11-15 | $12.93M 10-Q · filed 2020-11-10 | -$32.23M derived: sum of 4 quarters · filed 2021-09-08 | |||
| 2020-06-30 | $4.40M 10-Q · filed 2020-08-11 | $0.00 10-Q · filed 2021-08-16 | $8.72M 10-Q · filed 2020-08-11 | -$36.43M derived: sum of 3 quarters · filed 2021-09-08 | -$22.93M derived: sum of 4 quarters · filed 2021-09-08 | |||
| 2020-03-31 | $4.40M 10-Q · filed 2021-05-13 | $4.36M 10-Q · filed 2020-05-12 | -$40.83M derived: sum of 2 quarters · filed 2021-09-08 | -$27.33M derived: sum of 3 quarters · filed 2021-09-08 | -$10.43M derived: sum of 4 quarters · filed 2021-09-08 | |||
| 2019-12-31 | -$45.23M derived: 8-K 12 month − 10-Q 9 month · filed 2021-09-08 | -$31.73M derived: sum of 2 quarters · filed 2021-09-08 | -$14.83M derived: sum of 3 quarters · filed 2021-09-08 | $1.97M 8-K · filed 2021-09-08 | $52.66M 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $13.50M 10-Q · filed 2020-11-10 | $13.45M 10-Q · filed 2019-11-14 | $30.40M derived: sum of 2 quarters · filed 2020-11-10 | $47.20M 10-Q · filed 2020-11-10 | $47.19M 10-Q · filed 2019-11-14 | $66.42M derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $16.90M 10-Q · filed 2020-08-11 | $16.87M 10-Q · filed 2019-08-08 | $33.70M 10-Q · filed 2020-08-11 | $33.74M 10-Q · filed 2019-08-08 | $52.92M derived: sum of 3 quarters · filed 2020-08-11 | $72.22M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $16.90M 10-Q · filed 2020-05-12 | $16.87M 10-Q · filed 2019-05-09 | $36.02M derived: sum of 2 quarters · filed 2020-05-12 | $55.32M derived: sum of 3 quarters · filed 2020-05-12 | $74.62M derived: sum of 4 quarters · filed 2020-05-12 | |||
| 2018-12-31 | $19.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $38.42M derived: sum of 2 quarters · filed 2020-03-19 | $57.72M derived: sum of 3 quarters · filed 2020-03-19 | $77.10M 10-K · filed 2020-03-19 | $77.10M 10-K · filed 2019-03-28 | |||
| 2018-09-30 | $19.30M 10-Q · filed 2019-11-14 | $38.60M derived: sum of 2 quarters · filed 2019-11-14 | $57.98M 10-Q · filed 2019-11-14 | $57.98M 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | $19.30M 10-Q · filed 2019-08-08 | $38.67M 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | $19.37M 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $43.38M 8-K · filed 2019-12-20 |